JP2024540479A - ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン - Google Patents
ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン Download PDFInfo
- Publication number
- JP2024540479A JP2024540479A JP2024529329A JP2024529329A JP2024540479A JP 2024540479 A JP2024540479 A JP 2024540479A JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024540479 A JP2024540479 A JP 2024540479A
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- igm protease
- coli
- antigen
- streptococcus suis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
- C12N1/066—Lysis of microorganisms by physical processes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21208911.4 | 2021-11-18 | ||
| EP21208911 | 2021-11-18 | ||
| PCT/EP2022/082177 WO2023088988A1 (en) | 2021-11-18 | 2022-11-17 | A method to produce a vaccine against streptococcus suis and the said vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540479A true JP2024540479A (ja) | 2024-10-31 |
| JP2024540479A5 JP2024540479A5 (cg-RX-API-DMAC7.html) | 2025-10-20 |
Family
ID=78695535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529329A Pending JP2024540479A (ja) | 2021-11-18 | 2022-11-17 | ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240424077A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433079A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540479A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118265540A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023088988A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026114933A1 (en) | 2024-11-27 | 2026-06-04 | Intervet International B.V. | Stable vaccine against streptococcus suis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015181856A1 (ja) | 2014-05-30 | 2015-12-03 | 株式会社アーバンマテリアルズ | 弦楽器用エンドピン |
| EP2949340A1 (en) | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
| US11155585B2 (en) | 2015-07-09 | 2021-10-26 | Intervacc Ab | Vaccine against S. suis infection |
| AU2017214441B2 (en) * | 2016-02-04 | 2021-08-19 | Genovis Ab | New Streptococcal proteases |
-
2022
- 2022-11-17 EP EP22818340.6A patent/EP4433079A1/en active Pending
- 2022-11-17 US US18/708,248 patent/US20240424077A1/en active Pending
- 2022-11-17 JP JP2024529329A patent/JP2024540479A/ja active Pending
- 2022-11-17 WO PCT/EP2022/082177 patent/WO2023088988A1/en not_active Ceased
- 2022-11-17 CN CN202280076533.0A patent/CN118265540A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118265540A (zh) | 2024-06-28 |
| US20240424077A1 (en) | 2024-12-26 |
| EP4433079A1 (en) | 2024-09-25 |
| WO2023088988A1 (en) | 2023-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11814415B2 (en) | Vaccine against S. suis infection | |
| KR100361562B1 (ko) | 프로테이나제k에대해내성을갖는네이쎄리아메닝기티디스의표면단백질 | |
| US10039814B2 (en) | Glycoconjugate vaccines | |
| Fiske et al. | Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations | |
| CN114650840A (zh) | 一种针对副猪嗜血杆菌的新型疫苗 | |
| JP7812328B2 (ja) | ヘモフィルス・パラスイスに対する新規ワクチン | |
| JP2023517684A (ja) | ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン | |
| CN116063548B (zh) | 一种融合蛋白KP-Ag1及其用作肺炎克雷伯菌疫苗抗原的应用 | |
| US6979449B1 (en) | Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis | |
| CN107614534A (zh) | 猪胸膜肺炎放线杆菌重组毒素蛋白及其应用 | |
| US7201912B2 (en) | Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis | |
| EP4433079A1 (en) | A method to produce a vaccine against streptococcus suis and the said vaccine | |
| JPH10290695A (ja) | アクチノバシラス・プレウロニューモニアの弱毒化生菌 | |
| JP2024528169A (ja) | 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン | |
| US20100285070A1 (en) | Polynucleotides of haemophilus parasuis and its use | |
| JP2024528172A (ja) | 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン | |
| Iwanaga et al. | Pili of Vibrio cholerae widely distributed in serogroup O1 strains | |
| EP0282965B1 (en) | Treponema hyodysenteriae antigen and uses therefor | |
| RU2822516C1 (ru) | Новая вакцина против haemophilus parasuis | |
| JPWO1995034322A1 (ja) | ボルデテラ属菌産生壊死毒素の精製方法およびトキソイド | |
| WO2006113782A2 (en) | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof | |
| JPH02501732A (ja) | ブタ赤痢ワクチン | |
| RU2802072C2 (ru) | Вакцина для защиты от streptococcus suis | |
| Song et al. | Expression of Clostridium perfringens alpha-epsilon soluble fusion toxin gene in Escherichia coli and its immunogenicity in mice. | |
| US8420090B2 (en) | Recombinant B. pseudomallei adhesin protein and methods and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251009 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251009 |